The Anatolian Journal of Cardiology
Original Investigation

Chronic kidney disease: Prognostic marker of nonfatal pulmonary thromboembolism


Grigore T.Popa University of Medicine and Pharmacy; Iaşi-România; IIIrd Medical Clinic from Sf. Spiridon University Hospital; Iaşi-România


Grigore T.Popa University of Medicine and Pharmacy; Iaşi-România; Prof. George I.M. Georgescu Cardiovascular Institute Disease; Iaşi-România

Anatol J Cardiol 2015; 15: 938-943
DOI: 10.5152/akd.2014.5739
Read: 223 Downloads: 162 Published: 01 July 2021

Objective: Renal dysfunction is associated with increased cardiovascular morbidity and mortality. The alteration in renal function as a marker of mortality in pulmonary thromboembolism (PTE) has not been studied extensively. Methods: Four hundred four consecutive patients diagnosed with non-high-risk PTE (without cardiogenic shock or blood pressure <90 mm Hg) were prospectively enrolled in the study between 2005-2010. Kidney function, based on glomerular filtration rate (GFR), calculated by the simplified modification in diet in renal disease (MDRD) equation (sMDRD); troponin I; B-type natriuretic peptide (BNP); and echocardiographic markers of right ventricular (RV) function were determined in survivors versus non-survivors after a 2-year follow-up. Results: GFR was significantly lower in non-survivors than in survivors: 51.85±19.08 mL/min/1.73 m2 and 71.65±23.21 mL/min/1.73 m2, respectively (p=0.000). The highest 2-year mortality rate (20%) was recorded in patients with moderate renal dysfunction associated with RV dysfunction. Using multivariate analysis, we found that GFR is an independent predictor of 2-year mortality (OR 0.973, 95% CI: 0.959-0.987, p=0.000), besides troponin I, dyslipidemia, acceleration time of pulmonary ejection, pericardial effusion, and BNP. Conclusion: The association of renal dysfunction with right ventricular dysfunction in patients with non-fatal pulmonary thromboembolism resulted in high mortality. Renal dysfunction, assessed by glomerular filtration rate, may be used in the risk stratification of patients with non-high-risk pulmonary thromboembolism, besides troponin I, BNP, and right ventricle echocardiographic dysfunction markers.

ISSN 2149-2263 EISSN 2149-2271